Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome

Background: Lennox-Gastaut syndrome (LGS) is a severe form of childhood-onset epilepsy associated with serious injuries due to frequent and severe seizures. Of the antiepileptic drugs (AEDs) approved for LGS, clobazam is a more recent market entrant, having been approved in October 2011. Recent AED...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Clément François, John M. Stern, Augustina Ogbonnaya, Tasneem Lokhandwala, Pamela Landsman-Blumberg, Amy Duhig, Vivienne Shen, Robin Tan
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2017-01-01
Serie:	Journal of Market Access & Health Policy
Soggetti:	Lennox-Gastaut syndrome seizure antiepileptic drugs clobazam seizure-related costs
Accesso online:	http://dx.doi.org/10.1080/20016689.2017.1318691
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!